BioNTech CEO Ugur Sahin: "Our vaccine will likely work for …
WEBDec 22, 2020 · “Even though this new variant has multiple mutations, only one percent of this protein is changed. And that means 99 percent are still the same,” Biontech CE...
BioNTech Interview Questions - Glassdoor
WEBSep 5, 2024 · BioNTech interview details: 104 interview questions and 102 interview reviews posted anonymously by BioNTech interview candidates.
An mRNA Pioneer Discusses How Her Work Led to the COVID …
WEBSep 15, 2021 · Weissman quickly realized this virus was a perfect candidate for an mRNA vaccine, and Pfizer-BioNTech and Moderna soon pivoted to work on one. The rest is history.
The Husband-and-Wife Team Behind the Leading Vaccine to …
WEBNov 10, 2020 · The German company BioNTech, founded by two scientists, has teamed up with Pfizer on a vaccine that was found to be more than 90 percent effective.
BioNTech Founders Türeci and Şahin on the Battle against …
WEBJan 4, 2021 · In a DER SPIEGEL interview, BioNTech founders Özlem Türeci and Uğur Şahin discuss the development of the world's first COVID-19 vaccine, what that success means to them and where they intend...
Inside the hunt for a Covid-19 vaccine: how BioNTech made the …
WEBNov 13, 2020 · A vaccine candidate developed by the company they co-founded 12 years ago, BioNTech, was more than 90 per cent effective in preventing the disease — a far higher level than the widely-used jabs...
INTERVIEW: BioNTech founders Özlem Türeci and Ugur Sahin on …
WEBMar 23, 2021 · INTERVIEW: BioNTech founders Özlem Türeci and Ugur Sahin on developing the BioNTech-Pfizer COVID-19 vaccine, the future of fighting cancer, and whether people can live to 200. Mathias Döpfner....
'The science we did was important' – DW – 12/22/2020 - dw.com
WEBDec 22, 2020 · In an exclusive interview with DW's Konrad Busen, BioNTech CEO Ugur Sahin explains how the firm will respond to a new virus variant and why he hasn't been vaccinated.
BioNTech’s founder on the future of mRNA technology - The Economist
WEBJan 4, 2023 · Natasha Loder, The Economist’s health policy editor, talks to Ugur Sahin, the co-founder of BioNTech, whose covid vaccine changed the course of the pandemic. They consider the development of a ...
CNBC Exclusive: CNBC Transcript: BioNTech CEO Dr. Ugur Sahin …
WEBJan 11, 2021 · Following is the unofficial transcript of a CNBC EXCLUSIVE interview with BioNTech CEO Dr. Ugur Sahin on CNBC’s “Squawk Box” (M-F, 6AM-9AM ET) today, Monday, January 11 th. Following is a link...